Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

Clicks: 276
ID: 271652
1991
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The therapeutic activity of rimantadine and its relationship to the shedding of drug-resistant influenza A virus were assessed in two randomized, double-blind, placebo-controlled trials involving patients with laboratory-documented influenza A virus (H3N2 subtype) illness of 2 days' duration or less …
Reference Key
fg1991antimicrobialrecovery Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hayden FG;Sperber SJ;Belshe RB;Clover RD;Hay AJ;Pyke S;;
Journal Antimicrobial agents and chemotherapy
Year 1991
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/1952841
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't non-p.h.s. adult female male adolescent middle aged Child Infant P.H.S. preschool Clinical Trial Randomized Controlled Trial drug resistance microbial drug evaluation influenza human / drug therapy* influenza a virus / drug effects influenza a virus / isolation & purification* f g hayden rimantadine / therapeutic use* pmid:1952841 pmc245261 doi:10.1128/aac.35.9.1741 s j sperber s pyke

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.